ZYMOGENETICS INC (ZGEN) is a publicly traded company in the Unknown sector. Across all available filings, 28 corporate insiders have executed 746 transactions totaling $251.5M, demonstrating a bearish sentiment with -$197.2M in net insider flow. The most recent transaction on Oct 8, 2010 involved a transaction of 82,605,529 shares valued at $805.4M.
No significant insider buying has been recorded for ZGEN in the recent period.
No significant insider selling has been recorded for ZGEN in the recent period.
Based on recent SEC filings, insider sentiment for ZGEN is bearish with an Insider Alignment Score of 11/100 and a net flow of -$197.2M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at ZYMOGENETICS INC (ZGEN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 28 insiders are actively trading ZGEN stock, having executed 746 transactions in the past 90 days. The most active insider is Myers Squibb Co Bristol (Executive), who has made 1 transactions totaling $805.4M.
Get notified when executives and directors at ZGEN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 8, 2010 | Squibb Co Bristol Myers | Executive | Other | 82,605,529 | $9.75 | $805.4M | Large |
| Oct 8, 2010 | A. S. Novo Nordisk | Executive | Sale | 22,143,320 | $9.75 | $215.9M | Large |
| Oct 8, 2010 | L. A. Carter Bruce | Executive | Tender | 468,750 | $9.75 | $4.6M | Large |
| Oct 8, 2010 | L. Franklin Heather | Executive | Tender | 5,100 | $9.75 | $49.7K | |
| Oct 8, 2010 | R. Hamby Darren | Executive | Tender | 100 | $9.75 | $975 | |
| Oct 8, 2010 | A. Harper James | Executive | Tender | 4,000 | $9.75 | $39.0K | |
| Oct 8, 2010 | I. Hirsh David | Executive | Tender | 28,900 | $9.75 | $281.8K | |
| Oct 8, 2010 | A. Johnson James | Executive | Tender | 26,019 | $9.75 | $253.7K | |
| Oct 8, 2010 | Fruergaard Jorgensen Lars | Executive | Tender | 23,009,861 | $9.75 | $224.3M | Large |
| Oct 8, 2010 | Maccallum David | Executive | Tender | 10,000 | $9.75 | $97.5K | |
| Oct 8, 2010 | M. Miller Dennis | Executive | Tender | 3,599 | $9.75 | $35.1K | |
| Oct 8, 2010 | Anker Nielsen Kurt | Executive | Tender | 3,000 | $9.75 | $29.3K | |
| Oct 8, 2010 | Penhoet Edward | Executive | Tender | 72,000 | $9.75 | $702.0K | Large |
| Oct 8, 2010 | Ramos Eleanor | Executive | Tender | 3,599 | $9.75 | $35.1K | |
| Oct 8, 2010 | E. Williams Douglas | Executive | Tender | 4,600 | $9.75 | $44.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Other(J) | 1 | $805.4M | 54.6% |
Tender(U) | 15 | $413.5M | 28.1% |
Sale(S) | 222 | $224.4M | 15.2% |
Purchase(P) | 466 | $27.1M | 1.8% |
Exercise(M) | 34 | $3.4M | 0.2% |
Award(A) | 8 | $0 | 0.0% |
Insider selling pressure at ZYMOGENETICS INC has increased, with 28 insiders executing 746 transactions across all time. Total sales of $224.4M significantly outpace purchases of $27.1M, resulting in a net outflow of $197.2M. This selling activity appears largely discretionary, which may warrant closer attention from investors.